The James Turns Columbus Pink For Breast Cancer Awareness

October 05, 2012
The James Turns Columbus Pink For Breast Cancer Awareness

COLUMBUS, Ohio – In honor of Breast Cancer Awareness month, the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) is lighting the University and Columbus pink.

Several Ohio State buildings on campus and around the city will be illuminated with pink lights for the month of October as attention turns to Columbus Saturday (10/6) with the nationally televised Ohio State-Nebraska football game at 8 p.m.

Leading the way is the new James Cancer Hospital and Solove Research Institute and Critical Care Tower, under construction now near the corner of Cannon Drive and West 10th Avenue on the medical center campus. Spotlights will cast a pink glow, along with pink lights on the top floor of the 21-story building, and pink-lit ribbons on the two construction cranes.

Other buildings to be bathed in pink include:

  • Stefanie Spielman Comprehensive Breast Center, 1145 Olentangy River Road.
  • The Schottenstein Center, 555 Borror Dr.
  • Ohio State University Hospital East, 1492 E. Broad St.
  • Martha Morehouse Medical Tower, 2050 Kenny Road (only on Saturday 10/6)
  • CarePoint East, 543 Taylor Ave. (only on Saturday 10/6)

The pink buildings are a striking visual reminder of the importance of mammograms to screen for breast cancer, and the need for more funding for crucial breast cancer research, says Dr. Michael Caligiuri, director of Ohio State's Comprehensive Cancer Center and CEO of The James.

Slightly more than 60 percent of women in America who are 40 years or older have taken the time for a mammogram in the past two years, according to the Centers for Disease Control and Prevention. Yet for women diagnosed in the earliest stages of breast cancer, the survival rate is 93 percent. That compares to the 15 percent survival rate for those diagnosed with more advanced breast cancer, which accounts for one-third of all breast cancers, says Caligiuri.

"It's important to know that there are no routine ways to prevent, detect, treat and cure breast cancer," says Caligiuri. "Our breast radiologists specialize in reading and interpreting only mammograms, and those trained eyes on mammograms can mean the difference between a breast cancer that is detected at its earliest phases and those that go undiagnosed."

According to American Cancer Society guidelines, monthly self breast exams, a physical breast exam by a physician and annual mammograms after age 40 are key to helping detect breast cancer as early as possible.

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 41 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers and one of only seven centers funded by the NCI to conduct both phase I and phase II clinical trials. The NCI recently rated Ohio State's cancer program as "exceptional," the highest rating given by NCI survey teams. As the cancer program's 210-bed adult patient-care component, The James is a "Top Hospital" as named by the Leapfrog Group and one of the top cancer hospitals in the nation as ranked by U.S. News & World Report.

# # #

Contact: Eileen Scahill, Wexner Medical Center Public Affairs and Media Relations, 614-293-3737, or Eileen.Scahill@osumc.edu

Contact Media Staff

Amanda Harper

Director of Media Relations


614-685-5420 (direct)


614-293-3737 (main)


Amanda.Harper2@osumc.edu


Media staff are available by calling 614-293-3737 Monday through Friday between 8 a.m. and 5 p.m.

 

If after hours, please call 614-293-8000 (ask the operator to page the hospital administrative manager).

Latest News

New Clinical Trial Aims to Reprogram Cells to Attack a Specific Relapsed Blood Cancer

An upcoming clinical trial at The James aims to reprogram a patient’s immune cells to attack a specific relapsed blood cancer, called multiple myeloma. The idea is to “super-charge” the patient’s immune...

Read More

NCCN Publishes New Guidelines for Smoking Cessation, Effort Led by Ohio State Oncologist

To meet the needs of patients who are smokers at the time of a cancer diagnosis, the National Comprehensive Cancer Network has published smoking cessation guidelines. Ohio State's Peter Shields, MD...

Read More

Molecules in Prostate Tumors Might Predict Whether RT Can Help Prevent Recurrence

A new study has identified a group of molecules in prostate-cancer cells that doctors might one day use to distinguish which patients should be treated with radiation therapy if rising PSA levels...

Read More